carbapenems has been researched along with Empyema in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, P; Kong, Y; Liang, Y; Liu, Z; Lu, H; Ma, Y; Sun, L; Sun, W; Tan, X; Wang, H | 1 |
| Cunningham, SA; Jeraldo, PR; Khare, R; Patel, R; Sadarangani, SP; Wilson, JW | 1 |
2 other study(ies) available for carbapenems and Empyema
| Article | Year |
|---|---|
Bacteriophage therapy for empyema caused by carbapenem-resistant Pseudomonas aeruginosa.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Empyema; Humans; Male; Phage Therapy; Pseudomonas aeruginosa; Pseudomonas Infections | 2022 |
Metronidazole- and carbapenem-resistant bacteroides thetaiotaomicron isolated in Rochester, Minnesota, in 2014.
Topics: Abscess; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacteroides; Bacteroides Infections; beta-Lactamases; Carbapenems; Diverticulitis, Colonic; DNA, Bacterial; Drug Resistance, Bacterial; Empyema; Genome, Bacterial; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Minnesota; Surgical Wound Infection | 2015 |